Partnered Radioligand Therapy Asset

About PepLib Biotech

PepLib Biotech is a China-based, privately held biotech focused on next-generation peptide drug discovery. The company has built a suite of proprietary technology platforms, including peptide library generation and screening technologies, to accelerate the identification of novel therapeutic candidates. It has secured high-profile partnerships with Novartis, Eli Lilly, and AstraZeneca, indicating validation of its platform, and has progressed to a Series B financing round to advance its pipeline. The company's strategy combines internal pipeline development with strategic out-licensing and collaboration deals.